Vor Biopharma Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vor Biopharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • Vor Biopharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$27.8M, a 7.14% increase year-over-year.
  • Vor Biopharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$118M, a 11.3% decline year-over-year.
  • Vor Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$118M, a 28% decline from 2022.
  • Vor Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$92.1M, a 33.7% decline from 2021.
  • Vor Biopharma Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$68.9M, a 59% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$118M -$27.8M +$2.14M +7.14% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$120M -$30.8M -$2.37M -8.34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 -$118M -$26.3M -$2.35M -9.83% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$116M -$33.2M -$9.4M -39.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$106M -$30M -$8.32M -38.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$97.8M -$28.4M -$5.7M -25.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$92.1M -$23.9M -$5.66M -31% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$86.4M -$23.8M -$5.23M -28.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$81.2M -$21.7M -$3.29M -17.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$77.9M -$22.7M -$9.01M -65.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$68.9M -$18.3M -$2.59M -16.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$66.3M -$18.6M -$6.77M -57.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$59.5M -$18.4M -$10.3M -128% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$49.2M -$13.7M -$5.87M -74.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$43.3M -$15.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$11.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$8.04M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$7.85M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.